Tower Research Capital (TRC)’s AIM ImmunoTech Inc. AIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-143
| Closed | -$1.75K | – | 5704 |
|
|
2025
Q1 | $1.75K | Sell |
143
-4
| -3% | -$49 | ﹤0.01% | 4650 |
|
|
2024
Q4 | $2.91K | Sell |
147
-6
| -4% | -$119 | ﹤0.01% | 4750 |
|
|
2024
Q3 | $4.12K | Sell |
153
-114
| -43% | -$3.07K | ﹤0.01% | 4666 |
|
|
2024
Q2 | $9.97K | Buy |
267
+85
| +47% | +$3.17K | ﹤0.01% | 4190 |
|
|
2024
Q1 | $8.57K | Sell |
182
-7
| -4% | -$329 | ﹤0.01% | 4000 |
|
|
2023
Q4 | $8.31K | Buy |
189
+180
| +2,000% | +$7.92K | ﹤0.01% | 4522 |
|
|
2023
Q3 | $420 | Sell |
9
-39
| -81% | -$1.82K | ﹤0.01% | 5569 |
|
|
2023
Q2 | $3.21K | Buy |
48
+29
| +153% | +$1.94K | ﹤0.01% | 5073 |
|
|
2023
Q1 | $1K | Buy |
19
+17
| +850% | +$895 | ﹤0.01% | 5745 |
|
|
2022
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 6989 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 7028 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 7134 |
|
|
2022
Q1 | $0 | Sell |
2
-47
| -96% | – | ﹤0.01% | 7240 |
|
|
2021
Q4 | $4K | Buy |
+49
| New | +$4K | ﹤0.01% | 5411 |
|
|
2021
Q3 | – | Sell |
-97
| Closed | -$21K | – | 6700 |
|
|
2021
Q2 | $21K | Buy |
+97
| New | +$21K | ﹤0.01% | 3868 |
|
|
2021
Q1 | – | Sell |
-125
| Closed | -$22K | – | 6103 |
|
|
2020
Q4 | $22K | Buy |
+125
| New | +$22K | ﹤0.01% | 3826 |
|
|
2016
Q1 | – | Hold |
0
| – | -$1K | – | 5901 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4392 |
|